PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-55.23%
Negative net income growth while MRVL stands at 6.10%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
2.30%
Some D&A expansion while MRVL is negative at -7.39%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
71.70%
Well above MRVL's 22.22% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
-6.63%
Both cut yoy SBC, with MRVL at -8.15%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-94.40%
Both reduce yoy usage, with MRVL at -152.26%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
1192.19%
AR growth while MRVL is negative at -190.07%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
340.24%
Some inventory rise while MRVL is negative at -127.39%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-38.96%
Negative yoy AP while MRVL is 921.39%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-131.42%
Negative yoy usage while MRVL is 76.99%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
85.39%
Well above MRVL's 163.64%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-61.05%
Both yoy CFO lines are negative, with MRVL at -59.01%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-37.50%
Negative yoy CapEx while MRVL is 40.25%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
16.51%
Purchases well above MRVL's 10.16%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-31.87%
Both yoy lines are negative, with MRVL at -35.17%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
-768.20%
We reduce yoy other investing while MRVL is 194.89%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-63.17%
Both yoy lines negative, with MRVL at -99.67%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-9.30%
We cut debt repayment yoy while MRVL is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-100.00%
Negative yoy issuance while MRVL is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.